Skip to content
DefDex

Federal award

CYTOSORBENTS MEDICAL INC

FA865019C6065

Contract

Obligated and Ceiling

Obligated (net)
$2,849,920.30
Ceiling (potential value, not spending)
$2,959,747.00
Current value
$2,959,747.00
Gross positive obligations
$2,959,747.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
CYTOSORBENTS MEDICAL INC · LSF2KFUSY4K7
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
CYTOSORBENTS MEDICAL INC · LSF2KFUSY4K7
Awarding agency
Department of War · sub-agency 5700 · office FA8650
Funding agency
Department of War · sub-agency 5700
Product or service (PSC)
AD91 · R&D- DEFENSE OTHER: OTHER (BASIC RESEARCH)
Industry (NAICS)
541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PIID
FA865019C6065
Award type code
D
Actions
5 · Sep 24, 2019 to May 9, 2024
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History5

Award actions
DateFYModAction typeObligationCompany in company totals
May 9, 2024FY2024P00004M$0.00
—
May 3, 2024FY2024P00003M−$109,826.70
—
Sep 16, 2022FY2022P00002A$0.00
—
Jun 30, 2021FY2021P00001M$0.00
—
Sep 24, 2019FY20190—$2,959,747.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.